Clinical Trial Update: Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating propiverine hydrochloride for neurogenic detrusor overactivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder Dysfunction
• Neurogenic Detrusor Overactivity
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Propiverine hydrochloride (propiverine)

Snippet

Sponsor: APOGEPHA Arzneimittel GmbH | Conditions: Neurogenic Urinary Bladder Disorder, Urinary Bladder, Neurogenic | Phase 3 | Status: COMPLETED